Crown Marketing (PINK:CWNM
, CWNM message board
) have been under promotional fire for quite a few weeks now, yet the campaign is showing no signs whatsoever of slowing down. The latest batch of emails
touting CWNM have made sure that the stock will not escape from the promotional spotlight any time soon. What will come out of it, though?
As it is, Equities Awareness Group have approached a hadful of promoters to raise the hype about CWNM after the company announced to have had a couple of patents on its controlled drug delivery technology approved and registered in South Africa. As much as this might be a positive step in CWNM's business development, there is no word of a similar success in the USA.
In fact, CWNM is by far not the first pharmceutical pink sheet willing to revolutionize the whole industry with its novel technology. It won't be the last pretender, either. At this stage, however, the company has a long way to go before turning profitable. There are a lot of clinical trials that must be undergone and they are time-consuming by default.
So, until CWNM comes up with updates that are capable of hitting a real cornerstone in the United States, the company will most likely have trouble being taken seriously by long-term investors. Not to mention that paid promotions will do nothing to turn the odds in their favour, either.
The latest pump in particular has already started cracking under the pressure of having to live up to the expectations of the guys at Equities Awareness Group. One hour into today's session, CWNM shares appear to have already exhausted their potential. Having opened at $0.14, CWNM peaked at $0.1454, providing a maximum profit opportunity of 3.78%, which is not exactly what paid pumps are made for, is it? Yet, if you take a look at the historical pump profiles of PennyStock MarketBulls and Marquee Penny Stocks, you will easily notice how poorly the stocks they promoted performed in the aftermath. Some of them have yet to regain their pre-promo values.